Apoptosis, proliferation, and Fas (APO-I, CD95)/Fas ligand expression in medullary carcinoma of the breast

被引:0
|
作者
Yakirevich, E
Maroun, L
Cohen, O
Izhak, OB
Rennert, G
Resnick, MB
机构
[1] Lady Davis Carmel Med Ctr, Dept Pathol, IL-34362 Haifa, Israel
[2] Rambam Med Hosp, Dept Pathol, Haifa, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[4] Lady Davis Carmel Med Ctr, Dept Surg, IL-34362 Haifa, Israel
[5] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, IL-34362 Haifa, Israel
来源
JOURNAL OF PATHOLOGY | 2000年 / 192卷 / 02期
关键词
breast; medullary carcinoma; apoptosis; TUNEL; proliferation; PCNA; Fas; FasL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medullary carcinoma (MC) of the breast is a unique subtype of infiltrating ductal carcinoma that is characterized by a prominent lymphoid infiltrate and improved prognosis. Activated granzyme B+/CD8(+) cytotoxic T-lymphocytes (CTLs) infiltrating tumour cell nests constitute a major subset within the lymphoid infiltrate. As CTLs destroy target tumour cells by triggering apoptosis, it mould be of interest to determine whether the apoptotic rate in MC is increased. This study evaluates the extent of apoptosis in relation to Fas (APO-1, CD95)/Fas ligand (FasL) expression in MC. Fourteen cases of typical MC (TMC) and 15 cases of atypical MC (AMC) classified according to the Ridolfi criteria, as well as 19 cases of poorly differentiated infiltrating ductal carcinoma (PDC) were evaluated. The apoptotic index (AI) was assessed by the TUNEL method on paraffin-embedded tissue. Cell proliferation was evaluated immunohistochemically by PCNA staining. The level of Fas/FasL expression was determined semiquantitatively by immunohistochemistry using a four-grade scoring system. The AI was significantly increased in TMC and AMC as opposed to the PDC subgroup (2.2 +/- 0.8, 2.1 +/- 0.8, and 1.3 +/- 0.6, respectively; p < 0.05). A significant proportion (31.8 +/- 7.9% in TMC and 25.8 +/- 9.7% in AMC) of the apoptotic tumour cells within tumour nests mere in close contact with CD3(+) lymphocytes. Increased apoptosis was not accompanied by increased proliferation of tumour cells. The extent of Fas expression did not differ between the three subgroups. FasL was expressed both by tumour infiltrating lymphocytes in MC and by tumour epithelium in all three subgroups. The observation that the majority of MCs express Fas and are infiltrated by lymphocytes expressing FasL suggests that increased apoptosis in MC is mediated by Fas/FasL. However, our observation that the majority of MCs also express Fast and the fact that tumours co-expressing Fas and FasL did not show increased apoptosis suggest that there may be additional cytotoxic pathways that lead to tumour apoptosis in MC. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [11] Fas (CD95/Apo-1)/Fas Ligand Expression in Neonates with Pontosubicular Neuron Necrosis
    Frank K H Van Landeghem
    Ursula Felderhoff-Mueser
    Axel Moysich
    Christine Stadelmann
    Michael Obladen
    Wolfgang Brück
    Christoph Bührer
    Pediatric Research, 2002, 51 : 129 - 135
  • [12] Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system
    Jaber, BL
    Perianayagam, MC
    Balakrishnan, VS
    King, AJ
    Pereira, BJG
    JOURNAL OF LEUKOCYTE BIOLOGY, 2001, 69 (06) : 1006 - 1012
  • [13] Fas (CD95/Apo-1) expression and apoptosis in myelodysplasia.
    Bouscary, D
    DeVos, J
    FontenayRoupie, M
    Melle, J
    Jondeau, K
    Picard, F
    Dreyfus, F
    Guesnu, M
    BLOOD, 1996, 88 (10) : 2544 - 2544
  • [14] CD95 and Fas ligand expression and apoptosis in rheumatoid arthritis.
    Cantwell, MJ
    Hua, T
    Zvaifler, NJ
    Kipps, TJ
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 287 - 287
  • [15] Regulation of apoptosis through CD95 (APO-1/FAS) receptor/ligand
    Debatin, KM
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 228 - 228
  • [16] CD95 (APO-1/FAS) AND THE CD95 LIGAND IN NORMAL AND MALIGNANT B-CELL APOPTOSIS
    DANIEL, PT
    MAPARA, MY
    BOMMERT, K
    BARGOU, RC
    KRAMMER, P
    DORKEN, B
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 831 - 831
  • [17] Increased expression of Fas (CD95/APO-I) in adult rat brain after kainate-induced seizures
    Tan, ZQ
    Levid, J
    Schreiber, SS
    NEUROREPORT, 2001, 12 (09) : 1979 - 1982
  • [18] Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus
    Silvestris, F
    Grinello, D
    Tucci, M
    Cafforio, P
    Dammacco, F
    LUPUS, 2003, 12 (01) : 8 - 14
  • [19] Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases
    Nozawa, K
    Kayagaki, N
    Tokano, Y
    Yagita, H
    Okumura, K
    Hasimoto, H
    ARTHRITIS AND RHEUMATISM, 1997, 40 (06): : 1126 - 1129
  • [20] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    D Bouscary
    J De Vos
    M Guesnu
    K Jondeau
    F Viguier
    J Melle
    F Picard
    F Dreyfus
    M Fontenay-Roupie
    Leukemia, 1997, 11 : 839 - 845